Korro Bio, Inc.
KRRO
$12.31
-$0.29-2.30%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 18.53% | -25.34% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 18.53% | -25.34% | |||
| Cost of Revenue | -23.66% | -38.64% | |||
| Gross Profit | 28.18% | 39.79% | |||
| SG&A Expenses | -5.37% | -12.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -15.51% | -29.08% | |||
| Operating Income | 17.44% | 29.28% | |||
| Income Before Tax | -173.55% | 29.91% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -177.07% | 29.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -177.07% | 29.91% | |||
| EBIT | 17.44% | 29.28% | |||
| EBITDA | 15.64% | 30.48% | |||
| EPS Basic | -176.38% | 29.92% | |||
| Normalized Basic EPS | 17.75% | 29.92% | |||
| EPS Diluted | -176.38% | 29.92% | |||
| Normalized Diluted EPS | 17.75% | 29.92% | |||
| Average Basic Shares Outstanding | 0.25% | 0.01% | |||
| Average Diluted Shares Outstanding | 0.25% | 0.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||